Trial Profile
A Randomized, Double-blind, Placebo-controlled, 3 Dose Level, Parallel Group Study of the Efficacy and Safety of Plecanatide in Adolescents 12 to < 18 Years of Age With Chronic Idiopathic Constipation (CIC)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Oct 2019
Price :
$35
*
At a glance
- Drugs Plecanatide (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Sponsors Bausch Health Companies
- 23 May 2019 Status changed from active, no longer recruiting to completed.
- 10 Jan 2019 Planned End Date changed from 1 Sep 2018 to 1 Apr 2019.
- 18 Jul 2018 Status changed from recruiting to active, no longer recruiting.